Loading...
Back to narrative

IHH: Future Margins And Payout Will Continue To Support Balanced Outlook

IHH: Dividend Payments And Profit Margins Will Influence Healthcare Sector Outlook

IHH logo
IHH
AnalystConsensusTarget
Not Invested
Published 01 Dec 2024

Update shared on 16 Dec 2025

Fair value Decreased 0.0014%
Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
19.2%
7D
1.2%

Narrative Update on IHH Healthcare Berhad

Analysts have marginally trimmed their price target on IHH Healthcare Berhad by about RM0.01, reflecting fine tuned expectations around long term revenue growth, profit margins, and valuation multiples, while maintaining an overall stable outlook on the business.

What's in the News

  • A special and extraordinary shareholders meeting is scheduled for January 20, 2026, at 14:00 Singapore Standard Time in Kuala Lumpur to consider key corporate matters and shareholder resolutions (company event notice).
  • The meeting will be held at The Summit 1 Ballroom, The Vertical, Connexion Conference and Event Centre, Bangsar South City, reflecting the company’s preference for centrally located venues accessible to regional investors (company event notice).
  • The extraordinary meeting status indicates that the proposed agenda items may include strategic, capital, or governance related decisions that require enhanced shareholder approval (company event notice).

Valuation Changes

  • Fair Value Estimate edged down slightly from MYR 8.86 to MYR 8.86, indicating a negligible downward adjustment in intrinsic value.
  • Discount Rate remained unchanged at 8.49 percent, implying that the risk and cost of capital assumptions remain stable.
  • Revenue Growth was revised fractionally higher from 8.09 percent to 8.09 percent, signaling a virtually unchanged long term growth outlook.
  • Net Profit Margin nudged up slightly from 8.48 percent to 8.48 percent, reflecting a marginally more optimistic view on operating efficiency and profitability.
  • Future P/E eased marginally from 36.37x to 36.37x, pointing to a very small reduction in the implied valuation multiple applied to future earnings.

Have other thoughts on IHH Healthcare Berhad?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.